HOME > LATEST
LATEST
-
BUSINESS FunPep Allergy Vaccine Misses Exploratory Efficacy Goals in PI
July 29, 2026
-
ORGANIZATION Radiopharma Group Seeks Faster NHI Coverage for PET Imaging Agents
July 28, 2026
-
REGULATORY Japan Panel Green-Lights GSK’s Hep B Drug, Brinsupri, Hyrnuo
July 28, 2026
-
BUSINESS Pfizer Brings Eisai into Nurtec Promotion in Japan
July 28, 2026
-
BUSINESS Celltrion, Nippon Kayaku Broaden Alliance in Biopharma Biz
July 28, 2026
-
REGULATORY Japanese Women Top Life Expectancy for 41st Year Running
July 28, 2026
-
BUSINESS Ishin Eyes Domestic Production of Allostem by August 2028
July 28, 2026
-
BUSINESS Enhertu Combo Bags EU Panel Nod in 1st-Line HER2 Breast Cancer
July 28, 2026
-
BUSINESS FDA Approves Otsuka’s ADHD Drug Simtriyo
July 28, 2026
-
REGULATORY MHLW Sets FY2027 Budget Priorities for Drug Discovery, Advanced Medicine
July 28, 2026
-
BUSINESS Chugai CEO Says M&A an Option as Strategic Investment Unit Takes Shape
July 28, 2026
-
COMMENTARY Rare Cancer Case Raises New Questions about AAV Gene Therapy Safety
July 27, 2026
-
REGULATORY Japan Enacts Revised Immunization Act, Opens Way for RSV Antibodies under NIP
July 27, 2026
-
BUSINESS Chugai Forms Strategic Investment Unit to Deepen Innovation Push; Record Japan Filings Eyed
July 27, 2026
-
BUSINESS Chugai Notches Strong H1 Growth on Key Products, Roche Exports
July 27, 2026
-
BUSINESS Meiji’s Hiyasta Hits PIII Goal in Advanced Melanoma
July 27, 2026
-
ORGANIZATION Generic, Biosimilar Society Adopts 2040 Vision for Japan’s Pharma Industry
July 27, 2026
-
REGULATORY PMDA Sees Drop in Japan-China Bilateral Regulatory Exchanges
July 27, 2026
-
REGULATORY MHLW to Hear Patient Groups on OTC-Like Drug Charge Exemptions
July 27, 2026
-
REGULATORY Japan to Clarify Non-Clinical Data Waivers for Repurposed Drugs, Ease Sakigake Rules
July 24, 2026
ページ
The Wednesday TableShe had been on virtual calls since eight in the morning. The screen glowed. Her eyes burned. Plugged into Teams across time zones, she was digitally connected yet entirely isolated from the reality of Japan’s pharma market.She needed…
